Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation-Reference-Cited by-同舟云学术

Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

Published:2024-02 Issue:1 Volume:16 Page:
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Min Byeong Hyun¹,Devi Shivani²,Kwon Goo Hyun¹,Gupta Haripriya¹,Jeong Jin-Ju¹,Sharma Satya Priya¹,Won Sung-Min¹,Oh Ki-Kwang¹,Yoon Sang Jun¹,Park Hee Jin¹,Eom Jung A¹,Jeong Min Kyo¹,Hyun Ji Ye¹,Stalin Nattan²,Park Tae-Sik²,Choi Jieun³,Lee Do Yup³,Han Sang Hak⁴,Kim Dong Joon¹,Suk Ki Tae¹^ORCID

Affiliation:

1. Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Republic of Korea

2. Department of Life Science, Gachon University, Sungnam, Republic of Korea

3. Department of Agricultural Biotechnology, Center for Food and Bioconvergence, Research Institute of Agricultural and Life Sciences, Seoul National University, Seoul, Republic of Korea

4. Department of Pathology, Hallym University College of Medicine, Chuncheon, Republic of Korea

Funder

Basic Science Research Program through the National Research Foundation of Korea

Ministry of Education, Science and Technology

Korea Institute for Advancement of Technology

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Gastroenterology,Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2024.2307568

Reference50 articles.

1. Mechanisms of NAFLD development and therapeutic strategies

2. MAFLD Enhances Clinical Practice for Liver Disease in the Asia-Pacific region

3. Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD

4. Influence of dietary macronutrients on liver fat accumulation and metabolism

5. Impact of gut microbiota on diabetes mellitus